Major reductions in radiation doses from PET/CT scans can be achieved by modifying the acquisition parameters for CT. Conventional radiographic examinations such as chest, abdominal and bone X-rays ...

Prostate cancer stands as the third most common cancer among Malaysian men, with 70 percent of cases diagnosed at advanced ...

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

Radiation from patients undergoing other diagnostic and therapeutic radionuclide procedures such as bone scans or radioiodine therapy may pose a risk of radiation exposure to medical staff and does ...